Nanotechnology Research Center (NTRC), The British University in Egypt (BUE), El-Sherouk City, Cairo 11837, Egypt.
Nanotechnology Research Center (NTRC), The British University in Egypt (BUE), El-Sherouk City, Cairo 11837, Egypt; Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Egypt.
Int J Biol Macromol. 2021 Feb 15;170:107-122. doi: 10.1016/j.ijbiomac.2020.12.133. Epub 2020 Dec 29.
This study targets to develop curcumin-loaded polyvinyl alcohol/cellulose nanocrystals (PVA/CNCs) membrane as localized delivery system for breast/liver cancer. A novel strategy was developed for enhancing encapsulation capacity and maximizing therapeutic efficiency of curcumin-loaded PVA/CNCs membranes. Membranes were prepared by solution-casting method using citric acid as crosslinker. SEM revealed that PVA/CNCs ratio (80:20) was chosen as the optimum for loading curcumin. FT-IR indicated that, curcumin was incorporated into PVA/CNCs in amorphous-phase via intermolecular hydrogen bond between curcumin and membrane components. Curcumin showed biphasic-release through burst-release of 41% of curcumin during the first hour, followed by sustained-release of 70% and 94% during 24 h and 48 h, respectively. In vitro cytotoxicity of PVA/CNCs/Curcumin membrane exhibited a selective inhibition proliferation of breast and liver cancer cells in a concentration-dependent without any toxic effect on normal cells. At high concentration (8 mg/ml) of PVA/CNCs/Curcumin, reduced viability to 35% and 7% of MCF-7 and Huh-7 cells, respectively; meanwhile high HFB-4 normal cell viability ≥80% was investigated. Antimicrobial activity of PVA/CNCs/Curcumin was investigated by multi-drug-resistant strains, and MIC values. PVA/CNCs/Curcumin membranes with concentration (40 mg/ml) showed broad-spectrum antimicrobial activities, thus inhibited ~96-99% of microbial growth. PVA/CNCs/Curcumin membranes could be as promised anti-infective biomaterials for breast and liver cancer wound healing.
本研究旨在开发负载姜黄素的聚乙烯醇/纤维素纳米晶体(PVA/CNCs)膜作为局部递送系统,用于治疗乳腺癌/肝癌。本研究提出了一种新的策略,用于提高负载姜黄素的 PVA/CNCs 膜的包封能力和最大治疗效率。采用柠檬酸作为交联剂,通过溶液浇铸法制备了膜。SEM 结果表明,当 PVA/CNCs 的比例为 80:20 时,姜黄素的负载效果最佳。FT-IR 结果表明,姜黄素通过与膜成分之间的分子间氢键以无定形相掺入 PVA/CNCs 中。姜黄素表现出双相释放,在最初的 1 小时内有 41%的姜黄素突释,随后在 24 小时和 48 小时时分别持续释放 70%和 94%。体外细胞毒性实验结果表明,PVA/CNCs/Curcumin 膜对乳腺癌和肝癌细胞具有选择性抑制增殖作用,且呈浓度依赖性,对正常细胞无任何毒性作用。在 PVA/CNCs/Curcumin 的高浓度(8 mg/ml)下,MCF-7 和 Huh-7 细胞的活力分别降低至 35%和 7%,而高浓度的 HFB-4 正常细胞活力仍保持在 80%以上。通过多药耐药菌株和 MIC 值研究了 PVA/CNCs/Curcumin 膜的抗菌活性。PVA/CNCs/Curcumin 膜在浓度为(40 mg/ml)时具有广谱的抗菌活性,可抑制~96-99%的微生物生长。PVA/CNCs/Curcumin 膜有望成为治疗乳腺癌和肝癌创面感染的新型抗感染生物材料。